Export

Nivolumab
Essential medicine status
General description

INN
Nivolumab
Medicine type
Biological agent
EML status history
First added in 2019 (TRS 1021) for Melanoma of skin
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Immunomodulators
  • Parenteral > General injections > IV: 10 mg per mL concentrate solution for infusion